MannKind Corporation · 9 hours ago
Analytical Development Co-op
MannKind Corporation focuses on the development and commercialization of innovative inhaled therapeutic products and devices. They are seeking a highly motivated individual to join the Analytical Development department supporting R&D testing of respiratory drug products.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Support R&D testing of inhaled dosage forms. Specific testing includes aerodynamic Particle Size Distribution (APSD) using cascade impactors and fast screening impactors
Assist with UPLC setup
Prepare standards and required solutions for UPLC analysis
Assist with any other laboratory activities as needed
Document, compile, review, and present data
Comply with safety guidelines and good laboratory practices which include the maintenance of laboratory documentation, written procedures and laboratory notebooks
Work with hazardous materials and chemicals in accordance with MannKind safety policies and procedures
Qualification
Required
Pursuing a bachelor's or master's degree in pharmaceutical sciences, chemical engineering, or bioengineering, preferably within 1-2 years of graduation
Strong general lab abilities (analytical skills are a plus)
Excellent problem solving and data analysis skills
Excellent oral and written communication skills
Ability to work effectively in a collaborative team environment
Attention to detail
Fluency in MS Office software
Accuracy in following instructions, generating data, and documenting data and procedures
Preferred
Prior experience within life sciences, pharmaceuticals, or biotech industries
You possess superior time management and organizational skills
Experience with general laboratory procedures is a plus
You have an intrinsic motivation to continually improve and optimize processes
You take the initiative to identify opportunities for improvement and act on them without needing constant direction
You are open to constructive criticism and use it to improve performance and grow professionally
Company
MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions.
Funding
Current Stage
Public CompanyTotal Funding
$475MKey Investors
Blackstone GroupDeerfield Capital Management
2025-08-06Post Ipo Debt· $75M
2021-03-02Post Ipo Debt· $200M
2018-12-01Post Ipo Equity· $40M
Recent News
2026-01-09
GlobeNewswire
2025-12-24
2025-12-24
Company data provided by crunchbase